Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylated microtubule-associated protein tau (p-tau) is a post-translationally modified form of the tau protein that plays a critical role in stabilizing and promoting the assembly of microtubules in neurons. Hyperphosphorylation of tau leads to its detachment from microtubules, aggregation, and the formation of neurofibrillary tangles, which are hallmarks of Alzheimer's disease and other tauopathies. Pathologically phosphorylated forms of tau are central biomarkers for Alzheimer’s disease diagnosis/progression tracking and are actively being pursued as therapeutic targets. Therapeutic strategies under investigation include kinase inhibitors, aggregation inhibitors, oligonucleotides reducing expression, and immunotherapeutics.
Various, including inhibition of tau phosphorylation, prevention of tau aggregation, enhancement of microtubule stability, and reduction of tau expression
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylated Microtubule-Associated Protein Tau (p-tau).